BETTIE SMITH: Open Payments
NPI 1871115584 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 7 payments from 5 companies in 2025. Trend: 2023 $296 · 2024 $700 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $159 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ABBVIE INC. | 1 | $118 |
| Lilly USA, LLC | 1 | $112 |
Products named: NUZYRA, Auvelity, MAVYRET, INGREZZA.
Industry payments across TX — which companies pay providers there.
